SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

CEO Troy Wilsons repeated open-market purchases of 100,000 shares have driven attention, with traders viewing the insider buying as a confidence signal and potential support for Kuras commercial launch and AML pipeline. Some remain cautious about valuation, cash burn, execution risk and the need for further KOMZIFTI sales growth and clinical data.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The tokens steep decline from its launch highs has renewed debate over whether it was a Trump-family pump-and-dump, with traders citing alleged insider profits, weak utility, and heavy losses among holders. A small minority remains bullish on a speculative meme-coin rebound, but the dominant reaction is bearish and dismissive.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas monetization of a minority stake in Aeroplan, combined with stronger-than-expected quarterly results, has driven attention as traders focus on the loyalty programs implied valuation, debt repayment and planned share buybacks. The community is broadly bullish on the value-unlocking potential and strong travel demand, though some remain cautious about fuel costs, rising expenses and the companys reported operating loss.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

A strong second-quarter earnings report, raised outlook, and expanded Anthropic partnership through Claudeforce have fueled a sharp Salesforce rally and renewed optimism that AI can monetizeand augment rather than replaceenterprise software. Bulls view the move as a break from the SaaSpocalypse narrative, while skeptics argue the reaction is overextended and that buybacks, acquisitions, and still-muted organic growth weaken the case for sustained gains.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that sports-event contracts are sports bets rather than federally regulated swaps is drawing attention as a regulatory win for DraftKings, potentially limiting Kalshi and other prediction-market competitors ability to bypass state sportsbook rules. Traders broadly view the decision as strengthening DraftKings competitive position, though some note the circuit split, possible Supreme Court review, and uncertainty over how prediction markets will affect DraftKings growth and margins.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural-gas storage injections, elevated production, and uncertainty around Freeport LNGs maintenance and restart are driving attention, with traders weighing excess domestic supply against heat-driven power demand and potential storage draws. The community is sharply divided: bears emphasize supply, contango, and BOILs leveraged decay, while bulls anticipate a short squeeze if hotter weather tightens balances.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Anticipation of Intellia completing its rolling BLA for lonvo-z, following positive Phase 3 HAELO results in hereditary angioedema, is driving attention as traders look toward potential FDA acceptance and commercialization. The community is largely bullish on the therapys one-time gene-editing potential, while bearish participants emphasize financing, commercialization risk, and heavy short interest.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Completion of Anktivas first German labeling and packaging run has fueled attention around ImmunityBios European commercialization and possible follow-on approvals in the UAE and Saudi Arabia. Traders are divided between viewing the rollout and potential lymphopenia/all-cancer expansion as major growth catalysts and questioning near-term revenue, valuation, and recurring short-term selloffs.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is currently trending as a primary beneficiary of the AI infrastructure supercycle, with institutional investors and the community closely debating its momentum alongside competitors like Super Micro Computer. While community sentiment is bolstered by strong enterprise demand and a resilient backlog, investors remain focused on how the company's hardware volume and margin expansion will sustain its current market valuation.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

Discussion is centered on MSTUs reported 1-for-10 reverse split, with traders debating its impact on share prices, options settlement, and liquidity. Bullish traders expect a rebound if Bitcoin and MSTR strengthen, while others cite daily decay, volatility, and repeated reverse splits as reasons for continued downside risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Feed

News

Sentiment

Info

Historical Prices

FLAG For Loot And Glory

Fundamentals

Connect Stocktwits to ChatGPT

Latest FLAG News